Antibiotics cost Nigerians triple pain after GSK exit – Business Day NG

Antibiotics cost Nigerians triple pain after GSK exit - Business Day NG

Nigerians are now paying three times more for antibiotics formerly made by British pharmaceutical giant GlaxoSmithKline (GSK), one year after its exit. Prices of GSK’s flagship products, Augmentin 228mg and 475mg, have risen by 307 percent and 328 percent respectively between August 2023 when the company exited Nigeria and August 2024, BusinessDay market findings show. … Read more